Premium
Fiberoptic bronchoscopy and bronchial mucosal biopsies in asthmatics undergoing long‐term high‐dose budesonide aerosol treatment
Author(s) -
Laursen L. C.,
Taudorf E.,
Borgeskov S.,
Kobayasi T.,
Jensen H.,
Weeke B.
Publication year - 1988
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.1988.tb00901.x
Subject(s) - medicine , bronchoscopy , bronchus , pathology , pharynx , budesonide , atrophy , connective tissue , lung , respiratory disease , asthma , radiology , surgery
Mucosal biopsies from the pharynx, right main stem bronchus and right lower lobe were obtained during flexible fiberoptic bronchoscopy and were examined with light microscopy (LM) and electron microscopy (EM) in 10 asthmatics after 11 month's (range 7–15 months) treatment with high doses of inhaled budesonide via the Nebuhaler®, i.e. 1600 μg daily. Results were compared with biopsies from 10 controls suspected of having focal, malignant lung diseases. Visual inspection of the trachebronchial tree showed no signs of atrophy, ulcerations or thrush patches, and LM and EM showed no specific signs of mucosa and connective tissue atrophy; however, epithelial desquamation was seen in the asthmatics. No complications were observed.